Madhu Sharma Selected Research

Neoplasms (Cancer)

1/2022	Computational challenges in detection of cancer using cell-free DNA methylation.
1/2022	Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer.
1/2020	Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy.
6/2019	Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
1/2018	Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Madhu Sharma Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2018
3	Sepsis (Septicemia) 11/2021 - 01/2010
2	Deglutition Disorders (Dysphagia) 01/2022 - 05/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Acidosis 01/2020 - 12/2018
2	Infections 01/2015 - 07/2003
1	COVID-19 01/2022
1	Cross Infection (Nosocomial Infection) 11/2021
1	Neonatal Sepsis 11/2021
1	Birth Weight (Birth Weights) 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2019
1	Poisoning 12/2018
1	Acinetobacter Infections 01/2015
1	Cysts 11/2014
1	Learning Disabilities (Learning Disability) 09/2010
1	Hypertension (High Blood Pressure) 09/2010
1	Rupture 07/2003

Drug/Important Bio-Agent (IBA)

2	Starch (Cornstarch)IBA 01/2022 - 05/2019
2	xanthan gum (xanthan)FDA LinkGeneric 01/2022 - 05/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2003
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	ribociclibIBA 01/2022
1	Coloring Agents (Dyes)IBA 11/2021
1	Hydroxyl RadicalIBA 01/2020
1	Free RadicalsIBA 01/2020
1	ManganeseIBA 01/2020
1	polyolIBA 06/2019
1	epalrestatIBA 06/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2019
1	EnzymesIBA 06/2019
1	Aldehyde Reductase (Aldose Reductase)IBA 06/2019
1	tocophersolanIBA 06/2019
1	MicellesIBA 06/2019
1	ProdrugsIBA 06/2019
1	Colloids (Colloid)IBA 05/2019
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 12/2018
1	Lidocaine (Xylocaine)FDA LinkGeneric 12/2018
1	aluminum phosphideIBA 12/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2015
1	AntigensIBA 11/2014
1	Antihypertensive Agents (Antihypertensives)IBA 09/2010
1	beta-Lactamases (beta-Lactamase)IBA 01/2010
1	Indicators and Reagents (Reagents)IBA 07/2003

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Length of Stay 11/2021
1	Photothermal Therapy 01/2020
1	Precision Medicine 01/2020
1	Continuous Renal Replacement Therapy 12/2018
1	Renal Dialysis (Hemodialysis) 12/2018
1	Extracorporeal Membrane Oxygenation 12/2018